Cidara Therapeutics, Inc. reports

Company location: San Diego, CA
Fiscal year end: 31 December

Cidara Therapeutics, Inc. has filed 798 SEC EDGAR filings since 17 Jun 2014

Filter by type:
10-K
10-Q
8-K
SC13D
SC13G

SEC filing history

Showing 301-325 of 798 matching filings.

Per page

25

Current page

13

PRE 14A File 001-36912

PRE 14A

Filing date: 31 Oct 2022
Reporting date: 15 Dec 2022
SEC evidence: Open document Open filing
Next action: Verify source filing

8-K File 001-36912

FORM 8-K

Filing date: 21 Oct 2022
Reporting date: 18 Oct 2022
SEC evidence: Open document Open filing Open XBRL
Next action: Verify source filing

4

FORM 4

Filing date: 19 Sep 2022
Reporting date: 15 Sep 2022
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4

Filing date: 13 Sep 2022
Reporting date: 12 Sep 2022
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4

Filing date: 13 Sep 2022
Reporting date: 12 Sep 2022
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4

Filing date: 13 Sep 2022
Reporting date: 12 Sep 2022
SEC evidence: Open document Open filing
Next action: Verify source filing

8-K File 001-36912

FORM 8-K

Filing date: 08 Sep 2022
Reporting date: 02 Sep 2022
SEC evidence: Open document Open filing Open XBRL
Next action: Verify source filing

8-K File 001-36912

FORM 8-K

Filing date: 02 Sep 2022
Reporting date: 30 Aug 2022
SEC evidence: Open document Open filing Open XBRL
Next action: Verify source filing

8-K File 001-36912

FORM 8-K

Filing date: 09 Aug 2022
Reporting date: 09 Aug 2022
SEC evidence: Open document Open filing Open XBRL
Next action: Verify source filing

10-Q File 001-36912

CIDARA THERAPEUTICS, INC. FORM 10-Q

Filing date: 09 Aug 2022
Reporting date: 30 Jun 2022
SEC evidence: Open document Open filing Open XBRL
Next action: Verify source filing

8-K File 001-36912

FORM 8-K

Filing date: 27 Jul 2022
Reporting date: 26 Jul 2022
SEC evidence: Open document Open filing Open XBRL
Next action: Verify source filing

8-K File 001-36912

FORM 8-K

Filing date: 07 Jul 2022
Reporting date: 07 Jul 2022
SEC evidence: Open document Open filing Open XBRL
Next action: Verify source filing

4

FORM 4

Filing date: 24 Jun 2022
Reporting date: 22 Jun 2022
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4

Filing date: 24 Jun 2022
Reporting date: 22 Jun 2022
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4

Filing date: 24 Jun 2022
Reporting date: 22 Jun 2022
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4

Filing date: 24 Jun 2022
Reporting date: 22 Jun 2022
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4

Filing date: 24 Jun 2022
Reporting date: 22 Jun 2022
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4

Filing date: 24 Jun 2022
Reporting date: 22 Jun 2022
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4

Filing date: 24 Jun 2022
Reporting date: 22 Jun 2022
SEC evidence: Open document Open filing
Next action: Verify source filing

8-K File 001-36912

FORM 8-K

Filing date: 24 Jun 2022
Reporting date: 22 Jun 2022
SEC evidence: Open document Open filing Open XBRL
Next action: Verify source filing

8-K File 001-36912

FORM 8-K

Filing date: 11 May 2022
Reporting date: 11 May 2022
SEC evidence: Open document Open filing Open XBRL
Next action: Verify source filing

10-Q File 001-36912

CIDARA THERAPEUTICS, INC. FORM 10-Q

Filing date: 11 May 2022
Reporting date: 31 Mar 2022
SEC evidence: Open document Open filing Open XBRL
Next action: Verify source filing

DEFA14A File 001-36912

DEFINITIVE ADDITIONAL MATERIALS

Filing date: 29 Apr 2022
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing

DEF 14A File 001-36912

DEFINITIVE PROXY STATEMENT

Filing date: 29 Apr 2022
Reporting date: 22 Jun 2022
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4

Filing date: 04 Apr 2022
Reporting date: 31 Mar 2022
SEC evidence: Open document Open filing
Next action: Verify source filing

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. to update or revoke optional consent for future visits. For more information, see our Privacy Policy .